Cogent Biosciences's total assets for Q1 2025 were $283.80M, a decrease of -13.45% from the previous quarter. COGT total liabilities were $64.80M for the fiscal quarter, a -9.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.